INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 41h ago
HOUSE PTR1h ago
SEC 13F1h ago
ROBINHOOD CHAIN1h ago
GS
Corporate insider

Gryaznov Sergei

Chief Scientific OfficerCIK 0001913228

EDGAR filingsOpen in network
Disclosed transactions2
Buys / sells0 / 0
Max Insider Score9
Connections with evidence1

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
GS
Gryaznov SergeiChief Scientific Officer
MAIAMAIA Biotechnology, Inc.
Grant or award
A—
400.0K sh
May 29, 2026Jun 1, 2026
traded May 29, 2026
+3dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    MAIA Biotechnology, Inc.Chief Scientific Officer · Apr 14, 2026
9
GS
Gryaznov SergeiChief Scientific Officer
MAIAMAIA Biotechnology, Inc.
Grant or award
A
—
400.0K sh
Apr 10, 2026
Apr 14, 2026
traded Apr 10, 2026
+4d
SEC FORM 4

Evidence